AstraZeneca PLC Ordinary Shares (AZN)

Total Liabilities

$65.39B

Quarterly · Period ending: · USD

AZN logo

AZN Total Liabilities

Latest reported$65.39B
AZN Quarterly Total Liabilities ($5.10B → $65.39B)
High-resolution chart · PNG

AZN total liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

AstraZeneca PLC Ordinary Shares Total Liabilities — Quarterly (USD)
Period endingTotal Liabilities (USD)
65,386,550,000
66,631,000,000
65,355,000,000
68,485,000,000
67,612,000,000
65,122,000,000
63,164,000,000
64,117,000,000
64,742,000,000
64,792,000,000
61,953,000,000
58,865,000,000
59,127,000,000
60,876,000,000
59,425,000,000
59,031,000,000
60,628,000,000
63,914,000,000
66,076,000,000
67,309,000,000
57,948,000,000
50,480,000,000
51,091,000,000
50,494,000,000
46,271,000,000
44,995,000,000
46,781,000,000
45,237,000,000
46,818,000,000
49,026,000,000
46,607,000,000
47,906,000,000
47,072,000,000
48,708,000,000
46,712,000,000
49,140,000,000
49,707,000,000
46,180,000,000
45,857,000,000
48,310,000,000
49,029,000,000
47,681,000,000
41,615,000,000
36,750,000,000
36,870,000,000
36,745,000,000
38,949,000,000
35,698,000,000
36,487,000,000
37,913,000,000
32,646,000,000
30,674,000,000
30,575,000,000
29,841,000,000
29,582,000,000
30,187,000,000
29,150,000,000
29,042,000,000
29,358,000,000
28,422,000,000
29,591,000,000
31,987,000,000
32,717,000,000
34,078,000,000
32,382,000,000
33,187,000,000
34,099,000,000
32,346,000,000
32,258,000,000
30,986,000,000
30,724,000,000
31,972,000,000
34,107,000,000
33,591,000,000
33,042,000,000
31,208,000,000
32,633,000,000
15,543,000,000
14,516,000,000
13,339,000,000
13,450,000,000
14,516,000,000
11,149,000,000
11,158,000,000
11,314,000,000
11,149,000,000
11,097,000,000
9,552,000,000
11,540,000,000
11,370,000,000
10,316,000,000
9,489,000,000
9,415,161,445
10,358,045,567
10,350,000,000
8,983,216,683
9,211,215,000
9,495,700,867
12,682,252,154
9,113,631,056
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.